# Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder

> **NCT03948464** · PHASE3 · TERMINATED · sponsor: **M. Eugenia Socias** · enrollment: 27 (actual)

## Conditions studied

- Opioid-Related Disorders
- Opiate Substitution Treatment
- Morphine
- Methadone
- Fentanyl

## Interventions

- **DRUG:** Slow release oral morphine (SROM)
- **DRUG:** Methadone

## Key facts

- **NCT ID:** NCT03948464
- **Lead sponsor:** M. Eugenia Socias
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-06
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Study unable to proceed per protocol due to COVID-19 precautions
- **Last updated:** 2022-02-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03948464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03948464, "Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03948464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*